Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Verstappen CC, et al. Among authors: hoekman k. Drugs. 2003;63(15):1549-63. doi: 10.2165/00003495-200363150-00003. Drugs. 2003. PMID: 12887262 Review.
Reversible thyroid dysfunction during treatment with GM-CSF.
Hoekman K, von Blomberg-van der Flier BM, Wagstaff J, Drexhage HA, Pinedo HM. Hoekman K, et al. Lancet. 1991 Aug 31;338(8766):541-2. doi: 10.1016/0140-6736(91)91103-2. Lancet. 1991. PMID: 1678803
Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer.
Hoekman K, Wagstaff J, van Groeningen CJ, Vermorken JB, Boven E, Pinedo HM. Hoekman K, et al. J Natl Cancer Inst. 1991 Nov 6;83(21):1546-53. doi: 10.1093/jnci/83.21.1546. J Natl Cancer Inst. 1991. PMID: 1960751 Clinical Trial.
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
Dercksen MW, Hoekman K, ten Bokkel Huinink WW, Rankin EM, Dubbelman R, van Tinteren H, Wagstaff J, Pinedo HM. Dercksen MW, et al. Among authors: hoekman k. Br J Cancer. 1993 Nov;68(5):996-1003. doi: 10.1038/bjc.1993.468. Br J Cancer. 1993. PMID: 7692922 Free PMC article.
[Favorable results of paclitaxel (Taxol) in patients with ovary carcinoma pretreated with platinum].
Hoekman K, Huijskes RV, Burger CW, Verheijen RH, Pinedo HM, Vermorken JB. Hoekman K, et al. Ned Tijdschr Geneeskd. 1995 Feb 11;139(6):272-8. Ned Tijdschr Geneeskd. 1995. PMID: 7862216 Clinical Trial. Dutch.
[Primary high-dose chemotherapy with hematopoietic growth factors followed by surgery and radiotherapy in stage III breast carcinoma; a Phase II study in 15 patients].
Hoekman K, Wagstaff J, Vermorken JB, Meijer S, Meijer OW, Pinedo HM. Hoekman K, et al. Ned Tijdschr Geneeskd. 1994 May 21;138(21):1069-73. Ned Tijdschr Geneeskd. 1994. PMID: 8202179 Clinical Trial. Dutch.
Chemotherapy for gynecologic malignancies.
Vermorken JB, Hoekman K. Vermorken JB, et al. Among authors: hoekman k. Curr Opin Oncol. 1995 Sep;7(5):457-65. doi: 10.1097/00001622-199509000-00012. Curr Opin Oncol. 1995. PMID: 8541392 Review.
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.
Ogilvie AC, Hack CE, Wagstaff J, van Mierlo GJ, Erenberg AJ, Thomsen LL, Hoekman K, Rankin EM. Ogilvie AC, et al. Among authors: hoekman k. J Immunol. 1996 Jan 1;156(1):389-94. J Immunol. 1996. PMID: 8598489 Clinical Trial.
Incidence and prevention of nonhaematological toxicity of high-dose chemotherapy.
Hoekman K, Vermorken JB. Hoekman K, et al. Ann Med. 1996 Apr;28(2):175-82. doi: 10.3109/07853899609092943. Ann Med. 1996. PMID: 8732647 Review.
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.
Honkoop AH, Hoekman K, Wagstaff J, van Groeningen CJ, Vermorken JB, Boven E, Pinedo HM. Honkoop AH, et al. Among authors: hoekman k. Br J Cancer. 1996 Oct;74(7):1132-6. doi: 10.1038/bjc.1996.502. Br J Cancer. 1996. PMID: 8855987 Free PMC article. Clinical Trial.
118 results
Jump to page